CA2650197A1 - Structures de nanofibres presentes sur des asperites destinees a sequestrer, porter et transferer des substances - Google Patents

Structures de nanofibres presentes sur des asperites destinees a sequestrer, porter et transferer des substances Download PDF

Info

Publication number
CA2650197A1
CA2650197A1 CA002650197A CA2650197A CA2650197A1 CA 2650197 A1 CA2650197 A1 CA 2650197A1 CA 002650197 A CA002650197 A CA 002650197A CA 2650197 A CA2650197 A CA 2650197A CA 2650197 A1 CA2650197 A1 CA 2650197A1
Authority
CA
Canada
Prior art keywords
fragment
toxin
microneedles
present
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002650197A
Other languages
English (en)
Inventor
Darrell H. Reneker
Daniel J. Smith
David Barrett Meyers
Nevenka Golubovic-Liakopoulos
Alexander Marin
Alexander K. Andrianov
Peter G. Carroll
Sanford R. Simon
Tao Han
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Akron
Apogee Technology Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2650197A1 publication Critical patent/CA2650197A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
CA002650197A 2006-05-09 2007-05-09 Structures de nanofibres presentes sur des asperites destinees a sequestrer, porter et transferer des substances Abandoned CA2650197A1 (fr)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US79892806P 2006-05-09 2006-05-09
US60/798,928 2006-05-09
US84850706P 2006-09-29 2006-09-29
US84850406P 2006-09-29 2006-09-29
US84850506P 2006-09-29 2006-09-29
US84821306P 2006-09-29 2006-09-29
US84850606P 2006-09-29 2006-09-29
US60/848,505 2006-09-29
US60/848,507 2006-09-29
US60/848,504 2006-09-29
US60/848,506 2006-09-29
US60/848,213 2006-09-29
PCT/US2007/011228 WO2008024141A2 (fr) 2006-05-09 2007-05-09 Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances

Publications (1)

Publication Number Publication Date
CA2650197A1 true CA2650197A1 (fr) 2008-02-28

Family

ID=39107260

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002650197A Abandoned CA2650197A1 (fr) 2006-05-09 2007-05-09 Structures de nanofibres presentes sur des asperites destinees a sequestrer, porter et transferer des substances

Country Status (4)

Country Link
EP (1) EP2015803A4 (fr)
AU (1) AU2007288442A1 (fr)
CA (1) CA2650197A1 (fr)
WO (1) WO2008024141A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210268111A1 (en) * 2016-04-15 2021-09-02 Admbioscience Inc. Method for manufacturing nucleic acid film and apparatus for injecting medicine using nucleic acid film

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911749B2 (en) 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
EP2146689B1 (fr) 2007-04-16 2020-08-12 Corium, Inc. Réseaux de micro-aiguilles coulées dans un solvant contenant un actif
KR20110086854A (ko) * 2008-11-18 2011-08-01 쓰리엠 이노베이티브 프로퍼티즈 컴파니 중공 마이크로니들 어레이 및 방법
AU2015271878B2 (en) * 2010-04-28 2017-05-11 Sorrento Therapeutics, Inc. Device for delivery of rheumatoid arthritis medication
WO2011135531A2 (fr) * 2010-04-28 2011-11-03 Kimberly-Clark Worldwide, Inc. DISPOSITIFS MÉDICAUX POUR L'ADMINISTRATION D'ARNsi
EP2563455A4 (fr) * 2010-04-28 2014-02-19 Kimberly Clark Co Procédé d'augmentation de la perméabilité d'une barrière épithéliale
MX345837B (es) 2010-04-28 2017-02-16 Kimberly-Clark Worldwide Incorporated Dispositivo para la entrega de un medicamento para la artritis reumatoide.
KR20130058012A (ko) 2010-04-28 2013-06-03 킴벌리-클라크 월드와이드, 인크. 사출 성형된 마이크로니들 어레이 및 마이크로니들 어레이의 형성 방법
JP6327852B2 (ja) 2010-05-04 2018-05-23 コリウム インターナショナル， インコーポレイテッド 微小突起アレイを使用した副甲状腺ホルモンの経皮送達のための方法及びデバイス
WO2012130193A1 (fr) * 2011-03-31 2012-10-04 Zentiva, K.S. Complexes solubles non covalents de tériparatide contenant des polysaccharides et forme pharmaceutique de tériparatide pour administration orale
US20170246439A9 (en) 2011-10-27 2017-08-31 Kimberly-Clark Worldwide, Inc. Increased Bioavailability of Transdermally Delivered Agents
JP6535464B2 (ja) 2011-10-27 2019-06-26 ソレント・セラピューティクス・インコーポレイテッド 生理活性薬剤の送達のための移植可能な装置
MX343262B (es) 2011-10-27 2016-10-28 Kimberly Clark Co Administración transdérmica de agentes bioactivos de alta viscosidad.
WO2013086731A1 (fr) * 2011-12-16 2013-06-20 London Metropolitan University (Lmu) Appareil d'amenée
BR102012031955A2 (pt) * 2012-12-14 2014-10-07 Instituto De Pesquisas Tecnológicas Do Est S. Paulo S/A Ipt Nanofibras contendo substância ativa com liberação controlada para aplicação odontológica e processo
BR102012031954A2 (pt) * 2012-12-14 2015-01-20 Instituto De Pesquisas Tecnológicas Do Est S. Paulo S/A Ipt Nanofibras com subtância ativa para aplicação cosmética de liberação controlada obtidas por eletrofiação e processo
AU2013364053B2 (en) 2012-12-21 2018-08-30 Corium Pharma Solutions, Inc. Microarray for delivery of therapeutic agent and methods of use
CA2903748C (fr) 2013-03-12 2021-11-02 Corium International, Inc. Applicateurs de microprojection
BR112015022625B1 (pt) 2013-03-15 2023-01-31 Corium, Inc Aparelho de microestrutura para entrega de agente terapêutico
WO2014150285A2 (fr) 2013-03-15 2014-09-25 Corium International, Inc. Applicateurs de microprojection d'impacts multiples et procédés d'utilisation
AU2014237279B2 (en) 2013-03-15 2018-11-22 Corium Pharma Solutions, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
US9962534B2 (en) 2013-03-15 2018-05-08 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
KR101527469B1 (ko) * 2013-11-04 2015-06-11 연세대학교 산학협력단 다양한 삼차원 구조를 갖는 다공성 섬유 마이크로 구조체의 제조방법
WO2016036866A1 (fr) 2014-09-04 2016-03-10 Corium International, Inc. Matrice de microstructures, procédé de production et procédés d'utilisation
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
MX382197B (es) 2017-01-23 2025-03-13 Afyx Therapeutics As Metodo para la fabricacion de un producto de dos capas basado en fibras electrohiladas.
DE102017112573A1 (de) * 2017-06-07 2018-12-13 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation von Glukagon-ähnlichen-Peptid Analoga
US20240074970A1 (en) * 2019-10-08 2024-03-07 Afyx Therapeutics A/S Compositions for the delivery of proteins
KR102405984B1 (ko) * 2020-02-07 2022-06-08 카오카부시키가이샤 피부 외용 조성물
CN121752175A (zh) * 2023-07-25 2026-03-27 小利兰·斯坦福大学托管委员会 涉及高密度生物电子纤维的装置和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743211B1 (en) * 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
WO2005086773A2 (fr) * 2004-03-08 2005-09-22 Becton Dickinson And Company Methode d'administration de proteines therapeutiques dans le compartiment intradermique
US7786086B2 (en) * 2004-09-08 2010-08-31 Ramot At Tel-Aviv University Ltd. Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
US20060085063A1 (en) * 2004-10-15 2006-04-20 Shastri V P Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210268111A1 (en) * 2016-04-15 2021-09-02 Admbioscience Inc. Method for manufacturing nucleic acid film and apparatus for injecting medicine using nucleic acid film
US12329819B2 (en) * 2016-04-15 2025-06-17 Korea Institute Of Machinery & Materials Method for manufacturing nucleic acid film and apparatus for injecting medicine using nucleic acid film

Also Published As

Publication number Publication date
WO2008024141A8 (fr) 2009-07-09
WO2008024141A2 (fr) 2008-02-28
EP2015803A4 (fr) 2009-05-06
AU2007288442A1 (en) 2008-02-28
WO2008024141A3 (fr) 2008-04-24
EP2015803A2 (fr) 2009-01-21

Similar Documents

Publication Publication Date Title
AU2007288442A1 (en) Nanofiber structures on asperities for sequestering, carrying and transferring substances
US12377044B2 (en) Method and device for transdermal delivery of parathyroid hormone using a microprojection array
KR101728868B1 (ko) 안정성이 강화된 약학 조성물
KR101866005B1 (ko) 마이크로 니들 코팅용 조성물 및 마이크로 니들 디바이스
JP2021535928A (ja) 植込み型徐放微細針パッチ及びその調製方法
JPWO2010074239A1 (ja) マイクロニードルデバイス
US20200197286A1 (en) Soluble microneedle for delivering proteins or peptides
WO2016163753A1 (fr) Micro-aiguille soluble pour administrer des protéines ou des peptides
Dang et al. Nano-and microtechnology in skin delivery of vaccines
KR102567885B1 (ko) 선택된 방출 기간을 갖는 약제학적 조성물
US20200121831A1 (en) Microstructure Formulation Techniques for Botulinum Toxin
CN114630672B (zh) 肉毒杆菌毒素的微结构制备技术
CN109646673A (zh) 肉毒杆菌毒素的微结构制剂技术
CN100566669C (zh) 甲状旁腺激素药物的透皮释放装置
US10525111B2 (en) Microstructure formulation techniques for botulinum toxin
EP2533771A2 (fr) Système thérapeutique transdermique pour l'administration de peptides
Špánek et al. Nanofibers in Mucosal Drug and Vaccine Delivery
Dillon Development of Novel Transdermal Drug Delivery Technologies for Therapeutic Peptides
CN117083075A (zh) 皮肤病学组合物及其用途
HK40007558A (en) Microstructure formulation techniques for botulinum toxin
Chen et al. Poly-c-glutamic acid microneedles with as

Legal Events

Date Code Title Description
FZDE Discontinued